This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Cambridge Enterprise Limited, University of Cambridge. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Marko Juhana Hyvonen: Innovator in Pharmaceutical Chemistry
Introduction
Marko Juhana Hyvonen is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on benzo[c][2,6]naphthyridine derivatives.
Latest Patents
Hyvonen holds a patent for "Benzo[c][2,6]naphthyridine derivatives, compositions and therapeutic uses thereof." This patent includes a compound of the formula: (5-(2-(4-((3,5-difluoro-4-(trifluoromethoxy)benzyl)amino)butoxy)ethoxy)benzo[c][2,6]naphthyridine-8-carboxylic acid) or a pharmaceutically acceptable salt thereof. The patent also covers a pharmaceutical composition comprising the above compound, or a pharmaceutically acceptable salt thereof, along with a pharmaceutically acceptable excipient.
Career Highlights
Hyvonen is associated with Cambridge Enterprise Limited, where he continues to advance his research and development efforts. His work has the potential to impact therapeutic applications significantly.
Collaborations
He has collaborated with notable colleagues, including Paul Brear and David Robert Spring, contributing to a dynamic research environment.
Conclusion
Marko Juhana Hyvonen exemplifies innovation in pharmaceutical chemistry through his patented work and collaborations. His contributions are poised to make a lasting impact in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile